Skip to Main Content

Paper Details

Massively parallel knock-in engineering of human T cells.
Nat Biotechnol
17
2023
CAR, CAR-T variants, CAR-Ts, CD3, CD4, CD8, CLASH, CRISPR RNA, Cas12a, Cas12a/Cpf1 mRNA, Cpf1, PRDM1, blood cancer, cancer, crRNA, exon3, human, human T cells, mutant variants, primary human T cells, solid tumor, stem, transgene
Author NameAffiliation
Jonathan J ParkYale University School of Medicine
Jonathan J ParkYale University
Jonathan J ParkYale University
Jonathan J ParkCenter for Cancer Systems Biology, Yale University
Jonathan J ParkSystem Biology Institute, Yale University
Jianlei GuYale University School of Public Health
Hongyu ZhaoYale University School of Medicine
Hongyu ZhaoYale University School of Public Health
Hongyu ZhaoYale University
Hongyu ZhaoYale Center for Biomedical Data Science, Yale University School of Medicine
Sarah A SlavoffYale University
Sarah A SlavoffInstitute of Biomolecular Design and Discovery, Yale University
Sarah A SlavoffYale University
  • 1 - 13

Datasets

Release 1.2